Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CTLT

Catalent (CTLT) Stock Price, News & Analysis

Catalent logo

About Catalent Stock (NYSE:CTLT)

Advanced Chart

Key Stats

Today's Range
$63.48
$63.48
50-Day Range
$59.66
$63.48
52-Week Range
$58.28
$63.50
Volume
N/A
Average Volume
2.08 million shs
Market Capitalization
$11.52 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$63.50
Consensus Rating
Hold

Company Overview

Catalent Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

CTLT MarketRank™: 

Catalent scored higher than 20% of companies evaluated by MarketBeat, and ranked 893rd out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Catalent has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Catalent has received no research coverage in the past 90 days.

  • Read more about Catalent's stock forecast and price target.
  • Earnings Growth

    Earnings for Catalent are expected to grow by 73.08% in the coming year, from $0.78 to $1.35 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Catalent is -28.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Catalent is -28.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Catalent has a PEG Ratio of 2.69. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Catalent has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CTLT.
  • Dividend Yield

    Catalent does not currently pay a dividend.

  • Dividend Growth

    Catalent does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CTLT.
    Receive CTLT Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Catalent and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    CTLT Stock News Headlines

    “Fed Proof” Your Bank Account with THESE 4 Simple Steps
    Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.tc pixel
    Lisata Therapeutics signs research license with Catalent
    See More Headlines

    CTLT Stock Analysis - Frequently Asked Questions

    Catalent, Inc. (NYSE:CTLT) posted its earnings results on Tuesday, November, 5th. The company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.18. The business's revenue for the quarter was up 4.2% on a year-over-year basis.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Catalent investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Exxon Mobil (XOM).

    Company Calendar

    Last Earnings
    11/05/2024
    Today
    8/30/2025
    Fiscal Year End
    6/30/2026

    Industry, Sector and Symbol

    Stock Exchange
    NYSE
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NYSE:CTLT
    CIK
    1596783
    Employees
    16,900
    Year Founded
    2007

    Price Target and Rating

    High Price Target
    $63.50
    Low Price Target
    $63.50
    Potential Upside/Downside
    +0.0%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    3 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($2.26)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    81.38
    P/E Growth
    2.69
    Net Income
    -$1.04 billion
    Net Margins
    -9.28%
    Pretax Margin
    -7.83%
    Return on Equity
    -0.66%
    Return on Assets
    -0.24%

    Debt

    Debt-to-Equity Ratio
    1.38
    Current Ratio
    2.51
    Quick Ratio
    1.96

    Sales & Book Value

    Annual Sales
    $4.38 billion
    Price / Sales
    2.63
    Cash Flow
    $2.64 per share
    Price / Cash Flow
    24.04
    Book Value
    $19.91 per share
    Price / Book
    3.19

    Miscellaneous

    Outstanding Shares
    181,510,000
    Free Float
    180,949,000
    Market Cap
    $11.52 billion
    Optionable
    Optionable
    Beta
    1.15

    Social Links

    These 7 Stocks Will Be Magnificent in 2025 Cover

    Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

    Get This Free Report

    This page (NYSE:CTLT) was last updated on 8/30/2025 by MarketBeat.com Staff
    From Our Partners